ERWINAZE

Live / Registered — Registered and renewed (as of 23 Sept 2022)

What this means for you

Registered since 22 May 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 22 May 2022).

Record

Serial number
85245951
Registration number
4147569
Mark type
Stylized text
Filed
18 Feb 2011
Published for opposition
28 Jun 2011
Registered
22 May 2012
Next maintenance due
22 May 2022
Attorney of record
Rebecca Liebowitz

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical compositions and preparations, namely, injectable pharmaceutical compositions comprising compounds having asparaginase activity; pharmaceutical compositions and preparations for the treatment of hematological neoplasms, namely, leukemia

Owner

Prior registrations

Prosecution history

  • 23 Sept 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 23 Sept 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 23 Sept 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 23 Sept 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 29 Mar 2022 — TEAS SECTION 8 & 9 RECEIVED
  • 22 May 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 14 Apr 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 14 Apr 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 13 Apr 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 12 Apr 2018 — TEAS SECTION 8 RECEIVED
  • 01 Jul 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 13 Nov 2013 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 22 May 2013 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
  • 22 May 2012 — REGISTERED-PRINCIPAL REGISTER
  • 17 Apr 2012 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

View this trademark record on Marksy